Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05058287 · ClinicalTrials.gov registry record · Phase 3
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
A Phase 3 study of Pain, Postoperative and Opioid Use, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05058287 is a Phase 3 study of Pain, Postoperative and Opioid Use that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 150 participants, below the 271-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05058287, a Phase 3 study of Pain, Postoperative and Opioid Use, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Depo-Medrol 40Mg/Ml Suspension for Injection
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-11-05 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05058287
The ClinicalTrials.gov registry entry for NCT05058287 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 271-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (45% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05058287 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05058287 about?
NCT05058287 is a clinical study titled "Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression". This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.
What is the current status of trial NCT05058287?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2021-11-05. Estimated completion is 2026-12-31.
What conditions does trial NCT05058287 study?
This clinical trial studies the following conditions: Pain, Postoperative, Opioid Use, Lumbar Spinal Stenosis, Pain, Back.
What interventions are being tested in trial NCT05058287?
The interventions under investigation include: Placebo (DRUG), Depo-Medrol 40Mg/Ml Suspension for Injection (DRUG).
Who is sponsoring clinical trial NCT05058287?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05058287 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
COMPLETED · Phase 3
-
Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.